These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 7540419

  • 1. Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
    Salvagno L, Sorarù M, Sotti G, Aversa S, Chiarion Sileni V, Mazzarotto R, Scarzello G, Bianco A, Pappagallo GL, Fiorentino MV.
    Ann Oncol; 1995 Feb; 6(2):173-9. PubMed ID: 7540419
    [Abstract] [Full Text] [Related]

  • 2. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA, Leventhal B, Brecher ML, Marcus RB, Cantor A, Gieser PW, Ternberg JL, Behm FG, Wharam MD, Chauvenet AR.
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [Abstract] [Full Text] [Related]

  • 3. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
    Glick JH, Young ML, Harrington D, Schilsky RL, Beck T, Neiman R, Fisher RI, Peterson BA, Oken MM.
    J Clin Oncol; 1998 Jan; 16(1):19-26. PubMed ID: 9440718
    [Abstract] [Full Text] [Related]

  • 4. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
    Somers R, Carde P, Henry-Amar M, Tarayre M, Thomas J, Hagenbeek A, Monconduit M, de Pauw BE, Breed WP, Verdonck L.
    J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
    [Abstract] [Full Text] [Related]

  • 5. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
    De Lena M, Ditonno P, Lorusso V, Timurian A, Pellecchia A, Brandi M, Berardi F, Marzullo F.
    Haematologica; 1993 Feb; 78(4):230-5. PubMed ID: 7507457
    [Abstract] [Full Text] [Related]

  • 6. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
    Connors JM, Klimo P, Adams G, Burns BF, Cooper I, Meyer RM, O'Reilly SE, Pater J, Quirt I, Sadura A, Shustik C, Skillings J, Sutcliffe S, Verma S, Yoshida S, Zee B.
    J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
    [Abstract] [Full Text] [Related]

  • 7. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
    Brusamolino E, Lazzarino M, Orlandi E, Canevari A, Morra E, Castelli G, Alessandrino EP, Pagnucco G, Astori C, Livraghi A.
    Ann Oncol; 1994 Apr; 5 Suppl 2():101-6. PubMed ID: 7515642
    [Abstract] [Full Text] [Related]

  • 8. Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
    Viviani S, Bonadonna G, Santoro A, Bonfante V, Zanini M, Devizzi L, Soncini F, Valagussa P.
    J Clin Oncol; 1996 May; 14(5):1421-30. PubMed ID: 8622055
    [Abstract] [Full Text] [Related]

  • 9. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL, Glatstein E, Duffey PL, Young RC, Ihde DC, Bastian AW, Wilson WH, Wittes RE, Jaffe ES, Hubbard SM, DeVita VT.
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [Abstract] [Full Text] [Related]

  • 10. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
    Oberlin O, Leverger G, Pacquement H, Raquin MA, Chompret A, Habrand JL, Terrier-Lacombe MJ, Bey P, Bertrand Y, Rubie H.
    J Clin Oncol; 1992 Oct; 10(10):1602-8. PubMed ID: 1383434
    [Abstract] [Full Text] [Related]

  • 11. ABVD and radiation therapy as first-line treatment in advanced Hodgkin's disease.
    Zinzani PL, Magagnoli M, Frezza G, Barbieri E, Gherlinzoni F, Galuppi A, Bendandi M, Merla E, Albertini P, Babini L, Tura S.
    Leuk Lymphoma; 1999 Feb; 32(5-6):553-9. PubMed ID: 10048428
    [Abstract] [Full Text] [Related]

  • 12. Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
    Delwail V, Jais JP, Colonna P, Andrieu JM.
    Br J Haematol; 2002 Jul; 118(1):189-94. PubMed ID: 12100147
    [Abstract] [Full Text] [Related]

  • 13. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R, Gil-Fernández JJ, Muñoz E, Acevedo A, Sobrino MP, Fernández-Rañada JM.
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [Abstract] [Full Text] [Related]

  • 14. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 15. Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
    Viviani S, Bonadonna G, Santoro A, Zanini M, Zucali R, Negretti E, Valagussa P.
    Ann Oncol; 1991 Feb 01; 2 Suppl 2():55-62. PubMed ID: 1710921
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
    Chisesi T, Bellei M, Luminari S, Montanini A, Marcheselli L, Levis A, Gobbi P, Vitolo U, Stelitano C, Pavone V, Merli F, Liberati M, Baldini L, Bordonaro R, Pesce EA, Federico M.
    J Clin Oncol; 2011 Nov 10; 29(32):4227-33. PubMed ID: 21990405
    [Abstract] [Full Text] [Related]

  • 17. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
    Hutchinson RJ, Fryer CJ, Davis PC, Nachman J, Krailo MD, O'Brien RT, Collins RD, Whalen T, Reardon D, Trigg ME, Gilchrist GS.
    J Clin Oncol; 1998 Mar 10; 16(3):897-906. PubMed ID: 9508171
    [Abstract] [Full Text] [Related]

  • 18. Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.
    Fermé C, Lepage E, Brice P, D'Agay MF, Fermand JP, Castaigne S, Frija J, Miot C, Marty M, Gisselbrecht C.
    Int J Radiat Oncol Biol Phys; 1993 Jun 15; 26(3):397-405. PubMed ID: 7685749
    [Abstract] [Full Text] [Related]

  • 19. Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
    Brusamolino E, Orlandi E, Morra E, Castelli G, Pagnucco G, Livraghi A, Astori C, Santagostino A, Lazzarino M, Bernasconi C.
    Ann Oncol; 1994 Jun 15; 5 Suppl 2():53-7. PubMed ID: 7515648
    [Abstract] [Full Text] [Related]

  • 20. Treatment of childhood Hodgkin's disease without radiotherapy.
    van den Berg H, Zsiros J, Behrendt H.
    Ann Oncol; 1997 Jun 15; 8 Suppl 1():15-7. PubMed ID: 9187423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.